4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001422996-25-000009
President sold 50,000 shares at an average $20.26 ($1,012,764)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jaen Juan C. · President
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-17 | Sale : show line 1 in the form 10b5-1 | −37,114 | $20.23 | $750,720 | 1,049,946 | I |
| 2025-11-17 | Sale : show line 2 in the form 10b5-1 | −7,836 | $20.71 | $162,307 | 1,042,110 | I |
| 2025-11-18 | Sale : show line 3 in the form 10b5-1 | −5,050 | $19.75 | $99,738 | 1,037,060 | I |
| Open-market sales · 50,000 sh · avg $20.26 · $1,012,764 | ||||||
Loading xslF345X05/wk-form4_1763588347.xml…